ABclonal Technology Asia Pacific reposted this
Involving the immune system in fighting cancer is a popular #therapeuticstrategy. @Yurogen has developed a potent CD40-HER2 bispecific antibody therapy that could provide a blueprint for future antitumor treatment. Contact us today to see how we can help you accelerate your antibody drug pipeline!
